-
Get the latest information and research on osteoporosis.
-
Find treatment, guidance and advice on living with osteoporosis.
-
Share your experience and get involved. Joining the conversation is the first step to ending osteoporosis and broken bones.
NOF Taps PR Veteran Claire Gill to Lead Its Marketing Efforts
Washington, D.C. (January 14, 2013) – The National Osteoporosis Foundation (NOF), the nation’s leading health organization dedicated to preventing osteoporosis and broken bones, has named Claire Gill as its Senior Director of Marketing, Consumer and Corporate Outreach. Gill brings extensive experience in public relations and marketing communications to this newly-established role.
Gill joins NOF from Hunter Public Relations in New York, where she was a partner and spent more than a decade working for Fortune 500 clients in the food and beverage, consumer package goods and financial service industries. Prior to working for marketing agencies in New York, Gill led communications efforts for nonprofits in Washington, D.C. and New York promoting international diplomacy and the international fragrance industry, respectively.
“There is an incredible opportunity to raise awareness about bone health and osteoporosis in the United States,” Gill said. “Forty-four million Americans have low bone density or osteoporosis. This is not an ‘old person’s disease’ – it’s a young person’s disease that manifests itself as we age. We need to educate people about the disease and inspire them to take action to prevent it.”
“We’re excited to add Claire’s leadership and expertise to further our efforts to educate and advocate for better bone health,” said NOF CEO and Executive Director, Amy Porter. “Adding Claire to our executive team underscores NOF’s commitment to leading the effort to prevent osteoporosis and promote strong bones for life.”
Gill will spearhead outreach to consumers and corporations by leveraging a variety of existing NOF programs, including its Generations of Strength initiative focusing on bone health and family history and the Interdisciplinary Symposium on Osteoporosis (ISO13), taking place in Chicago from April 18-21 and featuring presentations by world class osteoporosis experts.
In addition, Gill will seek new public-private partnerships to continue spreading the word about osteoporosis and bone health.
The latest
Last week, a Food and Drug Administration (FDA) Panel voted that the risks of calcitonin salmon outweigh the benefits for the treatment of postmenopausal osteoporosis. The panel joined health authorities around the world in reviewing the drug’s safety after two recent studies showed slightly higher rates of cancer among patients taking calcitonin. The panel voted against continued use of the drug by a narrow majority, pointing out that it has not been found very effective in preventing bone fractures.
In today's Washington Post article "Calcium and Vitamin D findings show that caring for your bones can be compilicated," NOF's senior clinical director, Dr. Felicia Cosman helps clear up some of the confusion around the recent and conflicting research on calcium and vitamin D. She says: "It’s confusing, even for doctors. But there’s a common thread: None of the heart or kidney risks were associated with calcium from food."
CIRCA, the leading international buyer of fine jewelry, diamonds and watches, announced a new partnership with NOF at a Generations of Strength luncheon at the Friars Club in New York City on February 26. To kick-off the partnership, CIRCA’s Acting CEO Mary L. Forté presented NOF Executive Director and CEO Amy Porter with a check for $25,000, to support NOF’s mission.
Explore by tag
